Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2003
03/19/2003CN1403128A Chinese medicine for treating deep ulcer and bedsore
03/19/2003CN1403117A Compound vagina-cleaning flavescent sophora lotion
03/19/2003CN1403110A Crape myrtle-hibiscus pellet
03/19/2003CN1403108A Prepn of leukoderma-treating medicine
03/19/2003CN1403100A Trichogen and its prepn
03/19/2003CN1403097A Sore ulcer treating ointment and its prepn
03/19/2003CN1403088A Medicine composition containing polydatin or its salt and its use in preparing medicine
03/19/2003CN1403085A Medicine for inhibiting and killing body's superficial pathogenic fungi
03/19/2003CN1103230C External use ointment for treating pigmented naevus, senile plaque, freckle and plane warts and its preparing method
03/19/2003CN1103226C Medicine for treating burn and scald
03/19/2003CN1103222C External use medicinal liquid for treating psoriasis
03/19/2003CN1103220C Medicinal composition for treating optic atrophy
03/19/2003CN1103218C Ointment preparation for treating dermatosis and its preparing method
03/19/2003CN1103215C Antibaldness plant shampoo
03/19/2003CN1103214C Natural medicinal hair tonic
03/19/2003CA2422816A1 Disinfectant agent
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534630 Connective tissue growth factor-2
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534543 Oxa acids and related compounds for treating skin conditions
03/18/2003US6534531 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
03/18/2003US6534528 Treatment of a leg ulcer or a decubitus ulcer, wherein the ulcer is not infected, which comprises contacting the ulcer with a pharmaceutical which comprises a powder and at least one 1-hydroxy-2-pyridone
03/18/2003US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534497 Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534071 Surfactant free; care of dry and/or sensitive skin
03/18/2003US6534070 Composition with azelaic acid
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003CA2272705C Fused bicyclic pyrimidine derivatives
03/18/2003CA2176840C Combination of an antimicrobial compound with a glycerol monoalkylether
03/14/2003WO2002026710A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
03/14/2003CA2422613A1 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020754A2 Inhibition of replication factor c
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020749A2 Ncam binding compounds
03/13/2003WO2003020744A1 Methylene-4-azasteroids
03/13/2003WO2003020719A1 1,3-benzothiazinone derivatives and use thereof
03/13/2003WO2003020716A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003WO2003020711A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
03/13/2003WO2003020325A2 Methods for sterilizing preparations containing albumin
03/13/2003WO2003020324A2 Methods for sterilizing preparations of digestive enzymes
03/13/2003WO2003020311A1 Remedies for skin diseases
03/13/2003WO2003020309A2 Compound
03/13/2003WO2003020304A2 Inflammation modulatory compound comprising an endomorphin
03/13/2003WO2003020297A2 Method of improving wound healing
03/13/2003WO2003020274A1 Treatment of atopic dermatitis
03/13/2003WO2003020257A2 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
03/13/2003WO2003020239A2 Increase in the skin-moisturising properties of polyols
03/13/2003WO2003020227A1 Compositions and methods relating to prevention of chemotherapy-induced alopecia
03/13/2003WO2003020203A2 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments
03/13/2003WO2003020037A1 Multivesicular emulsion topical delivery systems
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002100354A3 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002096498A3 Use of sheets for producing body compresses and a pre-product and device therefor
03/13/2003WO2002096447A3 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
03/13/2003WO2002089743A3 Use of compositions for treating rosacea
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/13/2003WO2002067760A3 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/13/2003WO2002060396A3 Hair follicle neogenesis by injection of follicle progenitor cells
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002050112A3 Isolation of purified tgf- 1 and tgf- 2 from bone tissue
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002046412A3 Regulation of angiogenesis with zinc finger proteins
03/13/2003WO2002046191A3 Urea substituted imidazoquinoline ethers
03/13/2003WO2002046188A3 Amido ether substituted imidazoquinolines
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002043762A3 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002038140A3 Therapeutic uses for ip3 receptor-mediated calcium channel modulators
03/13/2003WO2002036829A3 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
03/13/2003WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/13/2003WO2002020017A3 Use of ectoin or ectoin derivatives for stabilizing p53
03/13/2003WO2002015893A3 Treatment of wounds
03/13/2003WO2002010347A3 Directed differentiation of embryonic cells
03/13/2003WO2001088103A3 Compositions and methods for tissue dedifferentiation and regeneration
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050439 Polypeptide for use in the treatment of tumors and warts
03/13/2003US20030050325 Novel compounds of the indolecarboxylic family and use thereof
03/13/2003US20030050310 Hydroxamic acid derivatives as proteinase inhibitors
03/13/2003US20030050299 An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050293 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
03/13/2003US20030050289 Combination of drospirenone and an estrogen sulphamate for HRT
03/13/2003US20030050278 Agent and food for inhibiting IgE antibody
03/13/2003US20030050277 Oral skin improving agent, skin improving method, and food composition for improving skin
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050269 Polynucleotides and polypeptides of the erythropoietin gene
03/13/2003US20030050265 A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule encoding transforming growth factor-beta 2
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050249 Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030050238 Stable composition comprising epidermal growth factor as an active ingredient
03/13/2003US20030050234 Conotoxin peptide extracted from the venom of a marine snail, Conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics
1 ... 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 ... 1065